EP Biocomposites Limited has announced that its board of directors will meet on Tuesday, May 26, 2026. The primary agenda for this meeting is the approval of the draft audited financial statements for the financial year ended March 31, 2026.

The meeting marks the first board gathering for the company in the financial year 2026-27. It is scheduled to take place at 4:00 pm at the EP Kamat Group office located in Panaji, Goa.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has stated that the trading window for dealing in its securities is currently closed. This window will remain shut until 48 hours after the conclusion of the board meeting on May 26, 2026.

Meeting Details

The following table summarizes the key details regarding the upcoming board meeting:

The intimation was signed by Rajkumar Gajanan Kamat, Managing Director of the company.

EP Biocomposites Limited has announced a strategic technical consultancy agreement with the Indian Institute of Science (IISc), Bengaluru, marking a significant step toward strengthening its capabilities in advanced wastewater treatment solutions. The collaboration aims to enhance the company's technical and research-backed expertise through expert consultancy and design inputs from one of India's premier research institutions.

Partnership Overview

The agreement establishes a framework for technical collaboration focused on advanced wastewater treatment technologies. IISc will provide technical consultancy and expert advisory support for system design and process optimization, enabling EP Biocomposites to leverage cutting-edge research and scientific expertise in developing innovative treatment solutions.

Technical Scope and Capabilities

The collaboration centers on technical consultancy, design review, and expert inputs relating to non-biological wastewater treatment systems. This partnership is expected to enable EP Biocomposites to offer unique non-biological treatment solutions for wastewater recycling, representing a differentiated approach in the market. The agreement specifically focuses on:

• System design optimization
• Process efficiency enhancement
• Technical advisory support
• Expert inputs for non-biological treatment systems

Strategic Benefits and Market Impact

The partnership is designed to deliver multiple strategic advantages for EP Biocomposites. The collaboration is expected to enhance process efficiency, system reliability, and compliance with evolving environmental regulations. By leveraging IISc's research expertise, the company aims to differentiate its offerings in the competitive wastewater treatment market.

Alignment with Corporate Strategy

This technical collaboration aligns with EP Biocomposites' long-term strategy of providing innovative, environmentally responsible, and technology-driven solutions. The partnership supports the company's focus on sustainable water management practices and positions it to expand its presence in both industrial and municipal wastewater treatment applications.

The agreement structure ensures focused technical support while maintaining operational flexibility. IISc's involvement is limited to technical consultancy and advisory services, with construction, equipment supply, or post-installation operations requiring separate agreements if pursued in the future.